Accelerated radiotherapy for advanced laryngeal cancer

Acta Oncologica

Volumn 44, Issue 5, 2005, Pages 481-489

  Haugen, Hedda ^a   Johansson, Karl Axel ^a   Ejnell, Hasse ^a   Edström, Staffan ^a   Mercke, Claes ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; HEARING LOSS; HUMAN; INFECTION; KIDNEY DISEASE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; SEPSIS; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM STAGING; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 23944469592     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860510029950     Document Type: Article

References (27)

1. Haugen H, Johansson K-A, Mercke C. Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer. Int J Radiat Oncol Biol Phys 2002;52:109-19.
2. Garden AS, Forster K, Wong P-F, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice- daily treatment? Int J Radiat Oncol Biol Phys 2003;55:322-8.
3. Finizia C, Geterud Å, Holmberg E, Lindström J, Lundgren J, Klintberg C, et al. Advanced laryngeal cancer T3-T4 in Sweden: retrospective study 1986-1990. Survival and locoregional control related to treatment. Acta Otolaryngol 1996;116:906-12.
4. Union Internationale Contre le Cancer. TNM Classification of Malignant Tumors. Fourth Fully Revised Edition. Berlin, Heidelberg, New York, London, Paris, Tokyo: Springer-Verlag; 1987. p 24-26.
5. Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001;49:23-33.
6. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common Toxicity Criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:13-47.
7. Jörgensen K, Godballe C, Hansen O, Bastholt L. Cancer of the larynx. Treatment results after primary radiotherapy with salvage surgery in a series of 1005 patients. Acta Oncol 2002;41:69-76.
8. Nguyen-Tan PF, Le Q-T, Quynh-Thu L, Quivey J-M, Singer M, Terris DJ, Goffinet DR, et al. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys 2001;50:1172-80.
9. Harwood AR, Beale FA, Cummings BJ, Hawkins NV, Keane TJ, Rider WD. T3 glottic cancer: an analysis of dose time-volume factors. Int J Radiat Oncol Biol Phys 1980;6:675-80.
10. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ. T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys 1998;40:549-52.
11. Karim ABMF, Kralendonk JH, Njo KH, Tierie AH, Hasman A. Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic viewpoint. Int J Radiat Oncol Biol Phys 1987;13:1625-33.
12. Mendenhall WM, Parsons JT, Mancuso AA, Stringer SP, Cassisi NJ. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head and Neck 1996;18:24-35.
13. Wang CC, Nakfoor BM, Spiro IJ, Martin SP. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results. Cancer J Sci Am 1997;3:88-91.
14. MacKenzie RG, Franssen E, Balogh JM, Gilbert RW, Birt D, Davidson J. Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery. Int J Radiat Oncol Biol Phys 2000;47:65-71.
15. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Philips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
16. Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol 2003;42:443-61.
17. Dische S, Saunders M, Barett A, Harvey A, Gibson D, Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-36.
18. Overgaard J, Sand Hansen H, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared to six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. Lancet 2003;362:933-40.
19. Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. The Lancet 2000;355:949-55.
20. Monnerat C, Faivre S, Temam S, Bourhis J, Raymond E. End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol 2002;13:995-1006.
21. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radio-therapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8.
22. Castelijns JA, Becker M, Hermans R. Impact of cartilage invasion on treatment and prognosis of laryngeal cancer. Eur Radiol 1996;6:156-69.
23. Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Kubilis PS. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 1997;37:1011-21.
24. Castelijns JA, Golding RP, van Schaik C, Valk J, Snow GB. MR findings of cartilage invasion by laryngeal cancer: value in predicting outcome of radiation therapy. Radiology 1990;174:669-73.
25. Million RR. The myth regarding bone or cartilage involvement by cancer and the likelihood of cure by radiotherapy. Head and Neck 1989;11:30-40.
26. Becker M, Zbären P, Läng H, Stoupis C, Porcellini B, Vock P. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology 1995;194:661-9.
27. Zbären P, Becker M, Läng H. Staging of laryngeal cancer: endoscopy, computed tomography and magnetic resonance versus histopathology. Eur Arch Oto-Rhino- Laryngol Suppl 1997;50:1172-80.